Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Bristol Myers Squibb Stock Rises
Bristol Myers Squibb Stock Rises After Schizophrenia Drug Gets FDA Approval
Key Takeaways Bristol Myers Squibb's drug to treat schizophrenia was approved for use by the Food and Drug Administration.The pharmaceutical firm called Cobenfy the first new treatment for the illness in decades.
Bristol-Myers Squibb Likely To Revalue Higher Following New Drug Approval
Bristol-Myers Squibb's stock is set to rise with FDA approvals, acquisitions, and a strong oncology portfolio, despite potential risks. Read more on BMY here.
Bristol Myers Stock Jumps. Why FDA Approval for Its Schizophrenia Drug Is Groundbreaking.
Bristol Myers Squibb stock jumped after the pharma company won approval for its new schizophrenia drug late Thursday. “This drug takes the first new approach to schizophrenia treatment in decades,” the Food and Drug Administration said.
Business Wire
11h
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of ...
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...
health.wusf.usf.edu
10h
A new kind of drug for schizophrenia promises fewer side effects
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
1h
New drug for schizophrenics has experts excited
Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
IDF: Hezbollah leader killed
Helene: How to help
Houthis attack US warships
Congressional Gold Medal
Dow closes at record high
NC dam failure ‘imminent’
Haney sues Garcia
'Harry Potter' star dies
High-end brothel plea
ICE: Convicts roaming free
Van Gogh paintings attacked
Troops to leave some bases
NY ballot appeal rejected
Deposition in AI suit
Meta hit with privacy fine
Diocese reaches settlement
Promotes watch collection
Bill to use birth control
KY sues Express Scripts
Fed inflation gauge cools
US charges three Iranians
ISR targets Hezbollah HQ
Urgent safety alert for 737s
Ending password-sharing
50/50 ball ownership suit
Producing doc on Diddy
Fake Biden robocalls fine
Killer gets life sentence
Boxes to distribute Narcan
Pleads not guilty
Feedback